Literature DB >> 8361630

Selective neurotoxicity of COOH-terminal fragments of the beta-amyloid precursor protein.

K Fukuchi1, B Sopher, C E Furlong, A C Smith, N Dang, G M Martin.   

Abstract

The primary component of amyloid deposits found in the brains of patients with Alzheimer's disease is the beta-amyloid protein, a derivative of a much larger precursor protein (beta PP). We have previously reported that overexpression of carboxyl (COOH)-terminal fragments of beta PP from an integrated DNA construct leads to degeneration of neuronally differentiating mouse embryonic stem cells and that the neuronal degeneration is related to approximately 14- and 15-kDa COOH-terminal fragments of the precursor protein. We here demonstrate that these putative cytotoxic fragments contain intact beta-amyloid protein. When such transformed cell lines are treated with dimethyl sulfoxide to induce differentiation into muscle cells, however, the resulting muscle cells remain viable (as do control non-transformed cells), despite the production of comparable amounts of the 14- and 15-kDa fragments. These results are consistent with the hypothesis that particular COOH-terminal fragments of beta PP are amyloidogenic and neurotoxic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361630     DOI: 10.1016/0304-3940(93)90192-n

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  The gamma -secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus.

Authors:  Y Gao; S W Pimplikar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

Review 2.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

3.  Regional acetylcholinesterase activity and its correlation with behavioral performances in 15-month old transgenic mice expressing the human C99 fragment of APP.

Authors:  M Dumont; R Lalonde; J-F Ghersi-Egea; K Fukuchi; C Strazielle
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

4.  Pulse-chase experiments revealed beta-secretase cleavage from immature full-length amyloid precursor protein harboring the Swedish mutation. Implications for distinct pathways.

Authors:  B Urmoneit; J Turner; T Dyrks
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

5.  Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein.

Authors:  M L Oster-Granite; D L McPhie; J Greenan; R L Neve
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

6.  Construction of recombinant plasmid harboring APP717 mutation and preliminary study of APP proteolysis.

Authors:  Xiaoqing Li; Zheng Xue; Suming Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

7.  Novel tricyclic pyrone compounds prevent intracellular APP C99-induced cell death.

Authors:  Lee-Way Jin; Duy H Hua; Feng-Shiun Shie; Izumi Maezawa; Bryce Sopher; George M Martin
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

8.  Neprilysin deficiency-dependent impairment of cognitive functions in a mouse model of amyloidosis.

Authors:  M Hasan Mohajeri; David P Wolfer
Journal:  Neurochem Res       Date:  2009-02-06       Impact factor: 3.996

9.  Inactivation of γ-secretases leads to accumulation of substrates and non-Alzheimer neurodegeneration.

Authors:  Hermien Acx; Lutgarde Serneels; Enrico Radaelli; Serge Muyldermans; Cécile Vincke; Elise Pepermans; Ulrike Müller; Lucía Chávez-Gutiérrez; Bart De Strooper
Journal:  EMBO Mol Med       Date:  2017-08       Impact factor: 12.137

10.  Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence.

Authors:  B De Strooper; M Simons; G Multhaup; F Van Leuven; K Beyreuther; C G Dotti
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.